Randall Kaye
About Randall Kaye
Randall Kaye is the Chief Medical Officer with extensive experience in clinical development and medical affairs, having previously held leadership roles at SSI Strategy, Axsome Therapeutics, and Avanir Pharmaceuticals.
Randall Kaye Chief Medical Officer
Randall Kaye is a highly experienced Chief Medical Officer with a strong background in medical leadership and clinical development. He has held key positions at several prominent pharmaceutical companies, including his current role as Chief Medical Officer. His extensive experience in the industry has equipped him with the skills necessary to lead medical and scientific initiatives effectively.
Randall Kaye Education and Expertise
Randall Kaye earned an M.D., M.P.H., and B.S. degrees from George Washington University. He also notably served as a Research Fellow in Allergy and Immunology at Harvard Medical School, which fortified his foundational expertise in the medical field. His educational background underscores his profound knowledge and readiness to handle complex medical affairs and clinical development tasks.
Randall Kaye Background in Medical Affairs
Randall Kaye has a robust background in Medical Affairs, having served in various senior roles at several pharmaceutical companies. Notably, he built and integrated a Medical Affairs department at Scios Inc., where he was Vice President of Medical Affairs. He also recruited and managed the Medical Affairs department for InterMune Inc. His extensive tenure at Pfizer Inc., where he served in various Clinical Development and Medical Affairs positions for nearly a decade, further highlights his depth of experience in this crucial aspect of the pharmaceutical industry.
Randall Kaye Clinical Development Leadership
Throughout his career, Randall Kaye has demonstrated strong leadership in clinical development. As Chief Medical Officer for Avanir Pharmaceuticals, he focused on providing leadership and vision to clinical development and medical affairs. His role as Chief Medical Officer for Axsome Therapeutics further emphasized his ability to lead and drive clinical programs. His leadership roles highlight a consistent track record in steering clinical development and advancing medical science.
Randall Kaye former Chief Scientific Officer at SSI Strategy
Randall Kaye served as the Chief Scientific Officer for SSI Strategy, where he was responsible for guiding the scientific and clinical strategies of the company. This role involved overseeing scientific initiatives and ensuring the alignment of clinical and medical strategies with the overall business goals. His time at SSI Strategy added to his extensive portfolio of leadership roles in the medical and scientific communities.